非感染性葡萄膜炎的眼内治疗
Intraocular therapy in noninfectious uveitis.
作者信息
Modugno Rocco Luigi, Testi Ilaria, Pavesio Carlos
机构信息
Department of Neuroscience, Ophthalmology Unit, University of Padua, Padua, Italy.
Moorfields Eye Hospital, National Health Service Foundation Trust, 162 City Rd, Old Street, London, EC1V 2PD, UK.
出版信息
J Ophthalmic Inflamm Infect. 2021 Oct 10;11(1):37. doi: 10.1186/s12348-021-00267-x.
Abstract
Systemic corticosteroids and immunosuppressant agents are the mainstay of therapy for non-infectious uveitis (NIU). However, the risks associated with systemic administration and the need of delivering an effective and safe anti-inflammatory treatment targeted to the site of inflammation have prompt the use of local therapy in the management of NIU. This review will analyse the different local treatment options available, including corticosteroids, anti-vascular endothelial growth factor (VEGF), methotrexate and the recent biologics.
摘要
全身用皮质类固醇和免疫抑制剂是治疗非感染性葡萄膜炎（NIU）的主要手段。然而，全身给药相关的风险以及需要针对炎症部位提供有效且安全的抗炎治疗，促使人们在NIU的治疗中采用局部治疗。本综述将分析现有的不同局部治疗选择，包括皮质类固醇、抗血管内皮生长因子（VEGF）、甲氨蝶呤以及最近的生物制剂。
相似文献
1
Intraocular therapy in noninfectious uveitis.非感染性葡萄膜炎的眼内治疗
J Ophthalmic Inflamm Infect. 2021 Oct 10;11(1):37. doi: 10.1186/s12348-021-00267-x.
2
Efficacy and safety of intravitreal anti-tumour necrosis factor drugs in adults with non-infectious uveitis - a systematic review.玻璃体腔内抗肿瘤坏死因子药物治疗成人非感染性葡萄膜炎的疗效和安全性 - 系统评价。
Acta Ophthalmol. 2018 Sep;96(6):e665-e675. doi: 10.1111/aos.13699. Epub 2018 Mar 25.
3
New observations and emerging ideas in diagnosis and management of non-infectious uveitis: A review.非感染性葡萄膜炎的诊断和治疗中的新观察和新观点：综述。
Semin Arthritis Rheum. 2019 Dec;49(3):438-445. doi: 10.1016/j.semarthrit.2019.06.004. Epub 2019 Jun 10.
4
Local versus Systemic Therapy for Noninfectious Uveitis (NIU).非感染性葡萄膜炎（NIU）的局部治疗与全身治疗
Semin Ophthalmol. 2023 Jan;38(1):15-23. doi: 10.1080/08820538.2022.2152707. Epub 2022 Dec 5.
5
Intravitreal Sirolimus for the Treatment of Noninfectious Uveitis: Evolution through Preclinical and Clinical Studies.玻璃体内注射西罗莫司治疗非感染性葡萄膜炎：临床前和临床研究的进展。
Ophthalmology. 2018 Dec;125(12):1984-1993. doi: 10.1016/j.ophtha.2018.06.015. Epub 2018 Jul 27.
6
Perspectives for immunotherapy in noninfectious immune mediated uveitis.非传染性免疫介导性葡萄膜炎的免疫治疗展望。
Expert Rev Clin Immunol. 2021 Sep;17(9):977-989. doi: 10.1080/1744666X.2021.1956313. Epub 2021 Jul 26.
7
Management of noninfectious posterior uveitis with intravitreal drug therapy.玻璃体内药物治疗非感染性后葡萄膜炎的管理
Clin Ophthalmol. 2016 Oct 13;10:1983-2020. doi: 10.2147/OPTH.S89341. eCollection 2016.
8
Current Knowledge of Biologics in Treatment of Noninfectious Uveitis.生物制剂治疗非感染性葡萄膜炎的研究现状。
J Ocul Pharmacol Ther. 2022 Apr;38(3):203-222. doi: 10.1089/jop.2021.0098. Epub 2022 Feb 8.
9
Local treatment of infectious and noninfectious intermediate, posterior, and panuveitis: current concepts and emerging therapeutics.眼内中部、后部和全葡萄膜炎的局部治疗：当前的概念和新兴疗法。
Curr Opin Ophthalmol. 2020 May;31(3):174-184. doi: 10.1097/ICU.0000000000000651.
10
New Pharmacological Strategies for the Treatment of Non-Infectious Uveitis. A Minireview.治疗非感染性葡萄膜炎的新药理学策略。一篇小型综述。
Front Pharmacol. 2020 May 8;11:655. doi: 10.3389/fphar.2020.00655. eCollection 2020.
引用本文的文献
1
Update on non-infectious uveitis treatment: anti-TNF-alpha and beyond.非感染性葡萄膜炎治疗的最新进展：抗肿瘤坏死因子-α及其他疗法
Front Ophthalmol (Lausanne). 2024 Aug 2;4:1412930. doi: 10.3389/fopht.2024.1412930. eCollection 2024.
2
Fluocinolone acetonide 0.2 µg/day intravitreal implant in non-infectious uveitis affecting the posterior segment: EU expert user panel consensus-based clinical recommendations.用于影响后段的非感染性葡萄膜炎的醋酸氟轻松0.2µg/天玻璃体内植入物：基于欧盟专家用户小组共识的临床建议
J Ophthalmic Inflamm Infect. 2024 May 30;14(1):22. doi: 10.1186/s12348-024-00402-4.
3
Corticosteroid implants for chronic non-infectious uveitis.皮质类固醇植入物治疗慢性非感染性葡萄膜炎。
Cochrane Database Syst Rev. 2023 Aug 29;8(8):CD010469. doi: 10.1002/14651858.CD010469.pub4.
4
Systemic Administration of Acazicolcept, a Dual CD28 and Inducible T cell Costimulator Inhibitor, Ameliorates Experimental Autoimmune Uveitis.阿卡西考普特（一种双重 CD28 和诱导性 T 细胞共刺激抑制剂）全身给药可改善实验性自身免疫性葡萄膜炎。
Transl Vis Sci Technol. 2023 Mar 1;12(3):27. doi: 10.1167/tvst.12.3.27.
5
Treatment of Non-Infectious Posterior Uveitis with Dexamethasone Intravitreal Implants in a Real-World Setting.在真实世界中使用地塞米松玻璃体内植入物治疗非感染性后葡萄膜炎
Clin Ophthalmol. 2023 Feb 16;17:601-611. doi: 10.2147/OPTH.S393662. eCollection 2023.
6
Corticosteroid implants for chronic non-infectious uveitis.皮质类固醇植入物治疗慢性非感染性葡萄膜炎。
Cochrane Database Syst Rev. 2023 Jan 16;1(1):CD010469. doi: 10.1002/14651858.CD010469.pub3.
7
Efficacy and Safety of Tocilizumab in the Management of Non-Infectious Uveitis Failed with Conventional Immunomodulatory and Anti-TNFα Therapies.托珠单抗治疗常规免疫调节和抗 TNF-α 治疗失败的非感染性葡萄膜炎的疗效和安全性。
Ocul Immunol Inflamm. 2024 Aug;32(6):891-897. doi: 10.1080/09273948.2022.2126374. Epub 2022 Dec 21.
8
Commentary: Dexamethasone intravitreal implant therapy in Vogt-Koyanagi-Harada disease.述评：玻璃体内注射地塞米松植入物治疗Vogt-小柳-原田病
Indian J Ophthalmol. 2022 Jul;70(7):2470-2471. doi: 10.4103/ijo.IJO_1207_22.
本文引用的文献
1
Evaluation of fluocinolone acetonide 0.19 mg intravitreal implant in the management of birdshot retinochoroiditis.0.19毫克醋酸氟轻松玻璃体内植入物治疗鸟枪弹样视网膜脉络膜炎的疗效评估
Br J Ophthalmol. 2022 Feb;106(2):234-240. doi: 10.1136/bjophthalmol-2020-317372. Epub 2020 Nov 26.
2
Seven-Year Outcomes of Uveitic Macular Edema: The Multicenter Uveitis Steroid Treatment Trial and Follow-up Study Results.葡萄膜炎性黄斑水肿七年结局：多中心葡萄膜炎激素治疗试验及随访研究结果。
Ophthalmology. 2021 May;128(5):719-728. doi: 10.1016/j.ophtha.2020.08.035. Epub 2020 Sep 10.
3
Effect of a Fluocinolone Acetonide Insert on Recurrence Rates in Noninfectious Intermediate, Posterior, or Panuveitis: Three-Year Results.氟轻松醋酸酯插入剂对非感染性中、后或全葡萄膜炎复发率的影响：三年结果。
Ophthalmology. 2020 Oct;127(10):1395-1404. doi: 10.1016/j.ophtha.2020.04.001. Epub 2020 Apr 17.
4
Efficacy and Safety of Intravitreal Sirolimus for Noninfectious Uveitis of the Posterior Segment: Results from the Sirolimus Study Assessing Double-Masked Uveitis Treatment (SAKURA) Program.玻璃体内注射西罗莫司治疗后部非感染性葡萄膜炎的疗效和安全性：西罗莫司评估双盲葡萄膜炎治疗（SAKURA）计划的研究结果。
Ophthalmology. 2020 Oct;127(10):1405-1415. doi: 10.1016/j.ophtha.2020.03.033. Epub 2020 Apr 3.
5
Uveitis Therapy: The Corticosteroid Options.葡萄膜炎治疗：皮质类固醇选择。
Drugs. 2020 Jun;80(8):765-773. doi: 10.1007/s40265-020-01314-y.
6
Preliminary evaluation of YUTIQ™ (fluocinolone acetonide intravitreal implant 0.18 mg) in posterior uveitis.YUTIQ™（0.18毫克曲安奈德玻璃体内植入剂）治疗后葡萄膜炎的初步评估。
Ther Deliv. 2019 Oct;10(10):621-625. doi: 10.4155/tde-2019-0051. Epub 2019 Oct 30.
7
Intravitreal Dexamethasone Implant for Treatment of Sarcoidosis-Related Uveitis.玻璃体内注射地塞米松植入物治疗肉样瘤病相关性葡萄膜炎。
Adv Ther. 2019 Aug;36(8):2137-2146. doi: 10.1007/s12325-019-00989-4. Epub 2019 May 28.
8
Dexamethasone implantation in birdshot chorioretinopathy - long-term outcome.地塞米松植入治疗鸟枪弹样脉络膜视网膜病变——长期疗效
Int Med Case Rep J. 2018 Nov 30;11:349-358. doi: 10.2147/IMCRJ.S164206. eCollection 2018.
9
Toxicity and in vivo release profile of sirolimus from implants into the vitreous of rabbits' eyes.西罗莫司从植入物在兔眼玻璃体内的毒性及体内释放情况
Doc Ophthalmol. 2019 Feb;138(1):3-19. doi: 10.1007/s10633-018-9664-8. Epub 2018 Nov 19.
10
Effect of an Injectable Fluocinolone Acetonide Insert on Recurrence Rates in Chronic Noninfectious Uveitis Affecting the Posterior Segment: Twelve-Month Results.注射用氟轻松醋酸酯植入剂治疗影响后段的慢性非传染性葡萄膜炎的复发率：十二个月的结果。
Ophthalmology. 2019 Apr;126(4):601-610. doi: 10.1016/j.ophtha.2018.10.033. Epub 2018 Oct 25.
Zotero 插件